| human | Q5 |
| P2798 | Loop ID | 684795 |
| P496 | ORCID iD | 0000-0002-1843-227X |
| P1053 | ResearcherID | AAU-9039-2020 |
| P1153 | Scopus author ID | 55433000900 |
| P69 | educated at | Boston University | Q49110 |
| P108 | employer | Addiction Research Center | Q4681111 |
| P734 | family name | Jordan | Q1703599 |
| Jordan | Q1703599 | ||
| Jordan | Q1703599 | ||
| P735 | given name | Chloe | Q2668516 |
| Chloe | Q2668516 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | female | Q6581072 |
| Q98772920 | (±)VK4-40, a Novel D3 R Partial Agonist, Attenuates Cocaine Reward and Relapse in Rodents |
| Q98461173 | ACNP efforts toward reducing climate change |
| Q36372705 | Adolescent D-amphetamine treatment in a rodent model of ADHD: Pro-cognitive effects in adolescence without an impact on cocaine cue reactivity in adulthood |
| Q48527671 | Adolescent d-amphetamine treatment in a rodent model of attention deficit/hyperactivity disorder: impact on cocaine abuse vulnerability in adulthood |
| Q61473633 | CB2 receptor antibody signal specificity: correlations with the use of partial CB2-knockout mice and anti-rat CB2 receptor antibodies |
| Q89394372 | Cannabinoid CB1 receptor neutral antagonist AM4113 inhibits heroin self-administration without depressive side effects in rats |
| Q30581979 | Cocaine-seeking behavior in a genetic model of attention-deficit/hyperactivity disorder following adolescent methylphenidate or atomoxetine treatments |
| Q98945110 | Correction: ACNP efforts toward reducing climate change |
| Q57040179 | Deletion of the type 2 metabotropic glutamate receptor increases heroin abuse vulnerability in transgenic rats |
| Q52627438 | Discovery and development of varenicline for smoking cessation. |
| Q99614548 | Effects of the COVID-19 pandemic on gender representation among corresponding authors of Neuropsychopharmacology (NPP) manuscripts: submissions during January-June, 2020 |
| Q50303257 | Evolution of autism support and understanding via the World Wide Web. |
| Q91107496 | Genetic deletion of the dopamine D3 receptor increases vulnerability to heroin in mice |
| Q101237768 | Introduction to the Special Issue on "Informing Longitudinal Studies on the Effects of Maternal Stress and Substance Use on Child Development: Planning for the HEALthy Brain and Child Development (HBCD) Study" |
| Q58570522 | Juvenile exposure to methylphenidate and guanfacine in rats: effects on early delay discounting and later cocaine-taking behavior |
| Q93261576 | Modafinil potentiates cocaine self-administration by a dopamine-independent mechanism: possible involvement of gap junctions |
| Q93077274 | NPP (Neuropsychopharmacology): update on gender balance in journal function |
| Q36553806 | Neural regulation of the time course for cocaine-cue extinction consolidation in rats. |
| Q91314957 | Neuropsychopharmacology (NPP): gender balance in journal function |
| Q92407969 | Neuropsychopharmacology (NPP): relationships between online attention and citation counts |
| Q114258316 | Neuropsychopharmacology (NPP): update on relationships between online attention and citation counts |
| Q36681100 | Performance on a strategy set shifting task during adolescence in a genetic model of attention deficit/hyperactivity disorder: methylphenidate vs. atomoxetine treatments |
| Q34473917 | Performance on a strategy set shifting task in rats following adult or adolescent cocaine exposure. |
| Q90264041 | Perinatal Marijuana Use and the Developing Child |
| Q90903607 | Progress in brain cannabinoid CB2 receptor research: From genes to behavior |
| Q28075281 | Sensitive periods of substance abuse: Early risk for the transition to dependence |
| Q92284092 | Translating the atypical dopamine uptake inhibitor hypothesis toward therapeutics for treatment of psychostimulant use disorders |
| Q50304821 | Understanding differences in neurotypical and autism spectrum special interests through Internet forums |
| Q38635163 | Working memory and salivary brain-derived neurotrophic factor as developmental predictors of cocaine seeking in male and female rats. |
| Q51746781 | mGluR5 antagonism inhibits cocaine reinforcement and relapse by elevation of extracellular glutamate in the nucleus accumbens via a CB1 receptor mechanism. |
Search more.